SCHEMBL2201538

SCHEMBL2201538

O=C(c1c(C2CC2)nn(-c2cccc(C(F)(F)F)c2)c1C1CC1)N1CCC(N2CCC(O)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
TSHR P16473 3/20 0.42
LMNA P02545 3/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NLRP3 Q96P20 1/20 0.41
ACACB O00763 1/20 0.39
ACACA Q13085 1/20 0.39
ELANE P08246 1/20 0.39
MGLL Q99685 1/20 0.38
GAA P10253 1/20 0.38
RBP4 P02753 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CCR5 P51681 1/20 0.38
GPR52 Q9Y2T5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202958 0.93 L3MBTL1 (0.44) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2201595 0.92 L3MBTL3 (0.43) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2202061 0.90 ALDH1A1 (0.43) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2201653 0.90 KMT2A (0.41) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2201524 0.89 TSHR (0.46) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2200674 0.85 KMT2A (0.41) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2199414 0.85 KMT2A (0.41) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2199418 0.85 KMT2A (0.41) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2200200 0.84 TSHR (0.44) ALDH1A1TSHRLMNAHTTNPSR1
SCHEMBL2199954 0.83 KMT2A (0.44) ALDH1A1TSHRLMNAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
US-7977358-B2 Pyrazol derivatives HOFFMANN-LA ROCHE INC. (US) 2011-07-12 US disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed
US-20090029963-A1 PYRAZOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029963-A1 PYRAZOL DERIVATIVES CCR1, CCR3, CCRL2 ALDH1A1 1476/4885TSHR 572/4885LMNA 4701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.